MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis

Cancer Letters

Volumn 376, Issue 2, 2016, Pages 293-302

  Ma, Huabin ^a   Pan, Jin Shui ^b   Jin, Li Xin ^b   Wu, Jianfeng ^a   Ren, Yan Dan ^b   Chen, Pengda ^a   Xiao, Changchun ^a   Han, Jiahuai ^a  

^a XIAMEN UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Colorectal cancer; HIF1 ; MiR 17 92; TGFBR2; VEGFA

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 17 92; MICRORNA 18A; MICRORNA 19A; MICRORNA 20A; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN A; HIF1A PROTEIN, HUMAN; HIF1A PROTEIN, MOUSE; MIRN17-92 MICRORNA, HUMAN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VEGFA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA INDUCIBLE FACTOR 1 ALPHA GENE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR GENE; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; VASCULAR ENDOTHELIAL GROWTH FACTOR A GENE; ANIMAL; CANCER TRANSPLANTATION; CHEMICALLY INDUCED; COLITIS; COLORECTAL NEOPLASMS; DISEASE COURSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; TIME FACTOR; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; XENOGRAFT;

ANIMALS; AZOXYMETHANE; COLITIS; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HETEROGRAFTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE, NUDE; MICE, TRANSGENIC; MICRORNAS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84963516615     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.04.011     Document Type: Article

References (43)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin 2011, 61:69-90.
2. Siegel R., Desantis C., Jemal A. Colorectal cancer statistics. CA Cancer J. Clin 2014, 64:104-117.
3. Padi S.K., Zhang Q., Rustum Y.M., Morrison C., Guo B. MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology 2013, 145:437-446.
4. Meng X., Wu J., Pan C., Wang H., Ying X., Zhou Y., et al. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology 2013, 145:426-436. e1-e6.
5. Ji S., Ye G., Zhang J., Wang L., Wang T., Wang Z., et al. miR-574-5p negatively regulates Qki6/7 to impact beta-catenin/Wnt signalling and the development of colorectal cancer. Gut 2013, 62:716-726.
6. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
7. Mogilyansky E., Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 2013, 20:1603-1614.
8. Gerstein M.B., Kundaje A., Hariharan M., Landt S.G., Yan K.K., Cheng C., et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489:91-100.
9. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
10. Mavrakis K.J., Wolfe A.L., Oricchio E., Palomero T., de Keersmaecker K., McJunkin K., et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat. Cell Biol 2010, 12:372-379.
11. Conkrite K., Sundby M., Mukai S., Thomson J.M., Mu D., Hammond S.M., et al. miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev 2011, 25:1734-1745.
12. Jin H.Y., Oda H., Lai M., Skalsky R.L., Bethel K., Shepherd J., et al. MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J. 2013, 32:2377-2391.
13. Diosdado B., van de Wiel M.A., Terhaar Sive Droste J.S., Mongera S., Postma C., Meijerink W.J., et al. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br. J. Cancer 2009, 101:707-714.
14. Lanza G., Ferracin M., Gafa R., Veronese A., Spizzo R., Pichiorri F., et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol. Cancer 2007, 6:54.
15. Monzo M., Navarro A., Bandres E., Artells R., Moreno I., Gel B., et al. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 2008, 18:823-833.
16. Ma Y., Zhang P., Wang F., Zhang H., Yang Y., Shi C., et al. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat. Commun 2012, 3:1291.
17. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.
18. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol 2008, 9:405-414.
19. Jin H.Y., Gonzalez-Martin A., Miletic A.V., Lai M., Knight S., Sabouri-Ghomi M., et al. Transfection of microRNA mimics should be used with caution. Front. Genet 2015, 6:340.
20. Mudter J., Amoussina L., Schenk M., Yu J., Brustle A., Weigmann B., et al. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J. Clin. Invest 2008, 118:2415-2426.
21. Guo H., Jia Y., Shang M., Zhang Y., Xie F., Wang H., et al. Comparison of two in vitro angiogenesis assays for evaluating the effects of netrin-1 on tube formation. Acta Biochim. Biophys. Sin. (Shanghai) 2014, 46:810-816.
22. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003, 94:965-973.
23. Grivennikov S.I. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin. Immunopathol 2013, 35:229-244.
24. Kuhnert F., Kuo C.J. miR-17-92 angiogenesis micromanagement. Blood 2010, 115:4631-4633.
25. Koike T., Kimura N., Miyazaki K., Yabuta T., Kumamoto K., Takenoshita S., et al. Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8132-8137.
26. Magrini E., Villa A., Angiolini F., Doni A., Mazzarol G., Rudini N., et al. Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization. J. Clin. Invest 2014, 124:4335-4350.
27. Zhang L., Yu D., Hu M., Xiong S., Lang A., Ellis L.M., et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res 2000, 60:3655-3661.
28. Zeoli A., Dentelli P., Rosso A., Togliatto G., Trombetta A., Damiano L., et al. Interleukin-3 promotes expansion of hemopoietic-derived CD45+ angiogenic cells and their arterial commitment via STAT5 activation. Blood 2008, 112:350-361.
29. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2257-2261.
30. Dews M., Fox J.L., Hultine S., Sundaram P., Wang W., Liu Y.Y., et al. The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res 2010, 70:8233-8246.
31. Ikushima H., Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 2010, 10:415-424.
32. Shen G., Li X., Jia Y.F., Piazza G.A., Xi Y. Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol. Sin 2013, 34:336-341.
33. Taguchi A., Yanagisawa K., Tanaka M., Cao K., Matsuyama Y., Goto H., et al. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 2008, 68:5540-5545.
34. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol 1996, 16:4604-4613.
35. Cascio S., D'Andrea A., Ferla R., Surmacz E., Gulotta E., Amodeo V., et al. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J. Cell. Physiol 2010, 224:242-249.
36. Lei Z., Li B., Yang Z., Fang H., Zhang G.M., Feng Z.H., et al. Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 2009, 4. e7629.
37. Ponce M.L. Tube formation: an in vitro matrigel angiogenesis assay. Methods Mol. Biol 2009, 467:183-188.
38. Mukherji S., Ebert M.S., Zheng G.X., Tsang J.S., Sharp P.A., van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat. Genet 2011, 43:854-859.
39. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
40. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
41. Jiang H., Wang P., Wang Q., Wang B., Mu J., Zhuang X., et al. Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model. Am. J. Pathol 2014, 184:1355-1368.
42. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
43. Doebele C., Bonauer A., Fischer A., Scholz A., Reiss Y., Urbich C., et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010, 115:4944-4950.